Explore evidence

In infants (0–9 months), children (1–17 years) and adults, the prevalence of anti-SARS-CoV-2 antibodies was between 33% and 37%.

GabonCOVID-19published 2021BMC Research NotesOpenAlexdocument of 7 observationsDOI 10.1186/s13104-021-05570-3

6 patientsSix out of eight patients with malaria and COVID-19 co-infection had headaches.

GabonCOVID-19 · paludismepublished 2022The Pan African medical journalPubMeddocument of 6 observations

50.6 %During the second wave of COVID-19 in Gabon, lineage B.1.1.7 accounted for 50.6% of sequenced genomes.

GabonB.1.1.7 · COVID-19published 2022Frontiers in medicineeurope_pmcdocument of 13 observationsDOI 10.3389/fmed.2022.877391

33.7 %Among 837 patients with COVID-19 in Gabon from March to June 2020, 282 (33.7%) had mild symptoms.

GabonCOVID-19observed March to June 2020published 2021JAMA network openPubMeddocument of 10 observations

17.2 %592 out of 3464 people (17.2%) were diagnosed with SARS-CoV-2 infection.

GabonCOVID-19published 2021Scientific reportseurope_pmcdocument of 23 observations

83.5 %More than 80% of respondents knew that COVID-19 could be transmitted by touching an infected doorknob (83.5%).

GabonCOVID-19published 2021Knowledge, Attitude, and Practice During the COVID-19 Pandemic in South-east Gabon.europe_pmcdocument of 11 observationsDOI 10.21203/rs.3.rs-299801/v1

6 deathsAmong 495 RT-PCR-positive COVID-19 cases managed at the Regional Hospital of Lambaréné in 2020, 6 deaths occurred before diagnosis was made.

GabonCOVID-19observed 2020published 2022Medecine tropicale et sante internationalePubMeddocument of 6 observations

51.9 %51.9% of respondents were looking forward to getting the COVID-19 vaccine when available.

GabonCOVID-19published 2021Knowledge, Attitude, and Practice During the COVID-19 Pandemic in South-east Gabon.europe_pmcdocument of 11 observationsDOI 10.21203/rs.3.rs-299801/v1

Viral loads were significantly higher in nasopharyngeal samples than in oropharyngeal samples among confirmed COVID-19 cases in Gabon.

GabonCOVID-19published 2022F1000Researcheurope_pmcdocument of 2 observationsDOI 10.12688/f1000research.74378.2

86.77 %The crude seroprevalence of SARS-CoV-2 antibodies among 3659 participants in Gabon was 86.77%.

GabonCOVID-19observed up to December 2021published 2024SARS-CoV-2 Antibody Seroprevalence in Gabon: Findings from the Nationwide Household Serosueurope_pmcdocument of 6 observations

1,377 lineagesThe study identified 1377 distinct SARS-CoV-2 lineages in Africa.

GabonCOVID-19published 2026Viruseseurope_pmcdocument of 5 observations

27.7 %27.7% of the total population produced both anti-SARS-CoV-2 N-protein antibodies and anti-SARS-CoV-2 S-protein antibodies.

GabonCOVID-19published 2021BMC Research NotesOpenAlexdocument of 7 observationsDOI 10.1186/s13104-021-05570-3

Children aged 0–9 years had the lowest SARS-CoV-2 seroprevalence in Africa.

GabonCOVID-19published 2022BMJ global healtheurope_pmcdocument of 4 observationsDOI 10.1136/bmjgh-2022-008793

83.9 %More than 80% of respondents knew that COVID-19 could be transmitted by attending meetings (83.9%).

GabonCOVID-19published 2021Knowledge, Attitude, and Practice During the COVID-19 Pandemic in South-east Gabon.europe_pmcdocument of 11 observationsDOI 10.21203/rs.3.rs-299801/v1

The first wave of COVID-19 in Gabon occurred from March 2020 to August 2020.

GabonCOVID-19observed March 2020 to August 2020published 2022Frontiers in medicineeurope_pmcdocument of 13 observationsDOI 10.3389/fmed.2022.877391

86 patientsAmong 305 surveyed patients with COVID-19, 86 (28%) had diabetes, which posed a risk of adverse interactions with hydroxychloroquine.

GabonCOVID-19 · diabète (non précisé)published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 8 observations

90 %More than 80% of respondents knew that COVID-19 could be transmitted by kissing an infected person (90.0%).

GabonCOVID-19published 2021Knowledge, Attitude, and Practice During the COVID-19 Pandemic in South-east Gabon.europe_pmcdocument of 11 observationsDOI 10.21203/rs.3.rs-299801/v1

83 casesAmong 1161 suspected cases of COVID-19 in Gabon, 83 were confirmed cases.

GabonCOVID-19published 2022Epidemiology of first cases of SARS-CoV-2 infection, from March to April 2020, in Gaboneurope_pmcdocument of 2 observations

QTc prolongation exceeding 60 ms and/or a QTc value exceeding 500 ms at 48 h was the primary endpoint.

GabonCOVID-19published 2022Clinics and practiceeurope_pmcdocument of 5 observations

1 %1% (N = 7) of SARS-CoV-2 infected persons had respiratory failure, which resulted in death.

GabonCOVID-19published 2021Scientific reportseurope_pmcdocument of 23 observations

The second wave of COVID-19 in Gabon occurred from January 2021 to May 2021.

GabonCOVID-19observed January 2021 to May 2021published 2022Frontiers in medicineeurope_pmcdocument of 13 observationsDOI 10.3389/fmed.2022.877391

1 patientOne patient with malaria and COVID-19 co-infection died on day 5 of hospitalization.

GabonCOVID-19 · paludismepublished 2022The Pan African medical journalPubMeddocument of 6 observations

100 per_1The ratio of seroprevalence from infection to cumulative incidence of confirmed cases was 100:1 overall in Africa.

GabonCOVID-19published 2022BMJ global healtheurope_pmcdocument of 4 observationsDOI 10.1136/bmjgh-2022-008793

91.42 %The seroprevalence of SARS-CoV-2 antibodies in the 40–49 age group in Gabon was 91.42% (95% CI: 88.7–93.5).

GabonCOVID-19observed up to December 2021published 2024SARS-CoV-2 Antibody Seroprevalence in Gabon: Findings from the Nationwide Household Serosueurope_pmcdocument of 6 observations

36.4 %During the second wave of COVID-19 in Gabon, lineage B.1.1.318 accounted for 36.4% of sequenced genomes.

GabonB.1.1.318 · COVID-19published 2022Frontiers in medicineeurope_pmcdocument of 13 observationsDOI 10.3389/fmed.2022.877391